Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum.

Abstract:

:Intracellular protein transport in endothelial cells is selectively inhibited by homocysteine, a thiol amino acid associated with both thrombosis and atherosclerosis. In a previous study, homocysteine decreased cell surface expression of the surface transmembrane glycoprotein thrombomodulin without decreasing secretion of another endothelial cell protein, plasminogen activator inhibitor-1. To define further the effects of homocysteine on protein transport, we examined the processing and secretion of the multimeric glycoprotein von Willebrand factor (vWF) in human umbilical vein endothelial cells. Incubation with 2 mmol/L homocysteine resulted in complete loss of vWF multimers and prevented asparagine-linked oligosaccharide maturation, propeptide cleavage, and secretion; these effects are consistent with impaired exit from the endoplasmic reticulum (ER). Dimerization was only partially inhibited, suggesting that homocysteine causes retention of provWF in the ER without preventing dimer formation. In pulse-chase incubations, intracellular provWF was degraded before exiting the ER in homocysteine-treated cells. Homocysteine also inhibited the processing and secretion of a carboxyl-terminal truncation mutant of human provWF expressed in rat insulinoma cells, indicating that retention in the endoplasmic reticulum can be mediated by regions of provWF apart from the carboxyl-terminal 20-Kd segment. These results suggest that retention of secretory proteins in the ER is regulated by redox mechanisms and imply that the intracellular transport of multiple endothelial cell proteins may be altered in patients with homocystinuria.

journal_name

Blood

journal_title

Blood

authors

Lentz SR,Sadler JE

subject

Has Abstract

pub_date

1993-02-01 00:00:00

pages

683-9

issue

3

eissn

0006-4971

issn

1528-0020

journal_volume

81

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis.

    abstract::Mutations in PIEZO1 are the primary cause of hereditary xerocytosis, a clinically heterogeneous, dominantly inherited disorder of erythrocyte dehydration. We used next-generation sequencing-based techniques to identify PIEZO1 mutations in individuals from 9 kindreds referred with suspected hereditary xerocytosis (HX) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-05-786004

    authors: Glogowska E,Schneider ER,Maksimova Y,Schulz VP,Lezon-Geyda K,Wu J,Radhakrishnan K,Keel SB,Mahoney D,Freidmann AM,Altura RA,Gracheva EO,Bagriantsev SN,Kalfa TA,Gallagher PG

    更新日期:2017-10-19 00:00:00

  • Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome.

    abstract::The putative chemokine receptor BLR1 has been identified as the first G-protein-coupled receptor involved in B-cell migration and in microenvironmental homing to B-cell follicles and to germinal centers. In healthy individuals, expression of BLR1 is restricted to all mature recirculating B cells and to a subpopulation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Förster R,Schweigard G,Johann S,Emrich T,Kremmer E,Nerl C,Lipp M

    更新日期:1997-07-15 00:00:00

  • Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action.

    abstract::In this study, we examined in detail the interaction of platelet factor-4 (PF-4) with fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF) and the effect of PF-4-derived synthetic peptides. We show that a peptide between amino acids 47 and 70 that contains the heparin-binding lysine-rich si...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jouan V,Canron X,Alemany M,Caen JP,Quentin G,Plouet J,Bikfalvi A

    更新日期:1999-08-01 00:00:00

  • Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.

    abstract::To obtain insight into the mechanism(s) of posttransplantation humoral immunodeficiency, we evaluated factors affecting serum antibody levels against polio, tetanus, Haemophilus influenzae, and Streptococcus pneumoniae in 87 patients. Patients with hematologic malignancies were randomized to receive marrow versus bloo...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood-2002-05-1376

    authors: Storek J,Viganego F,Dawson MA,Herremans MM,Boeckh M,Flowers ME,Storer B,Bensinger WI,Witherspoon RP,Maloney DG

    更新日期:2003-04-15 00:00:00

  • HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism.

    abstract::The finding that the risk of relapse in hematologic malignancy decreases after allogeneic hematopoietic stem cell transplantation (HSCT) has lead to the concept of a graft-versus-leukemia (GVL) effect. However, this beneficial effect is considered to be frequently offset by graft-versus-host disease (GVHD). Thus, impr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-08-171934

    authors: Kawase T,Matsuo K,Kashiwase K,Inoko H,Saji H,Ogawa S,Kato S,Sasazuki T,Kodera Y,Morishima Y,Japan Marrow Donor Program.

    更新日期:2009-03-19 00:00:00

  • Prostaglandin E(2) regulates murine hematopoietic stem/progenitor cells directly via EP4 receptor and indirectly through mesenchymal progenitor cells.

    abstract::Prostaglandin E(2) (PGE(2)) regulates hematopoietic stem/progenitor cell (HSPC) activity. However, the receptor(s) responsible for PGE(2) signaling remains unclear. Here, we identified EP4 as a receptor activated by PGE(2) to regulate HSPCs. Knockdown of Ep4 in HSPCs reduced long-term reconstitution capacity, whereas ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-437889

    authors: Ikushima YM,Arai F,Hosokawa K,Toyama H,Takubo K,Furuyashiki T,Narumiya S,Suda T

    更新日期:2013-03-14 00:00:00

  • The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells.

    abstract::The regulatory Tat protein of human immunodeficiency virus type-1 (HIV-1) exerts a pleyotropic activity on the survival and proliferation of different cell types in culture. In this report, we investigated the effect of either endogenous or exogenous Tat on Bcl-2 proto-oncogene expression and cell survival in Jurkat T...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zauli G,Gibellini D,Caputo A,Bassini A,Negrini M,Monne M,Mazzoni M,Capitani S

    更新日期:1995-11-15 00:00:00

  • Isolation and characterization of an age-related antigen present on senescent human red blood cells.

    abstract::Autologous membrane-bound IgG was isolated from a subpopulation of human red blood cells (RBC) with specific density greater than 1.110, by affinity chromatography of purified RBC membrane glycoprotein preparations using immobilized wheat germ agglutinin and immobilized anti-human immunoglobulin (Ig) as immunoabsorben...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Alderman EM,Fudenberg HH,Lovins RE

    更新日期:1981-08-01 00:00:00

  • Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome.

    abstract::Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare primary immunodeficiency caused by gain-of-function mutations in the CXCR4 gene. We report the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of mavorixafor from a phase 2 open-label dose-escalatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020007197

    authors: Dale DC,Firkin F,Bolyard AA,Kelley M,Makaryan V,Gorelick KJ,Ebrahim T,Garg V,Tang W,Jiang H,Skerlj R,Beaussant Cohen S

    更新日期:2020-12-24 00:00:00

  • Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow.

    abstract::Hematologic engraftment and immune reconstitution were examined in patients who received cyclophosphamide and total body irradiation therapy followed by infusion of autologous bone marrow purged with anti-B1 monoclonal antibody (MoAb) and complement as therapy for non-Hodgkin's lymphoma. Hematologic engraftment was pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Anderson KC,Ritz J,Takvorian T,Coral F,Daley H,Gorgone BC,Freedman AS,Canellos GP,Schlossman SF,Nadler LM

    更新日期:1987-02-01 00:00:00

  • Chemotactic factor enhancement of superoxide release from fluoride and phorbol myristate acetate stimulated neutrophils.

    abstract::Human neutrophils exposed to chemotactic concentrations of zymosan-activated serum (ZAS) and a formylated chemotactic peptide (FMLP, 10(-7)--10(-9) M) were markedly enhanced in their ability to generate superoxide (O2-) upon stimulation with either sodium fluoride or phorbol myristate acetate (PMA). For both fluoride ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: English D,Roloff JS,Lukens JN

    更新日期:1981-07-01 00:00:00

  • Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.

    abstract::The bone marrow (BM) microenvironment consists of extracellular-matrix and the cellular compartment including immune cells. Multiple myeloma (MM) cell and BM accessory cell interaction promotes MM survival via both cell-cell contact and cytokines. Immunomodulatory agents (IMiDs) target not only MM cells, but also MM c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-279893

    authors: Görgün G,Calabrese E,Soydan E,Hideshima T,Perrone G,Bandi M,Cirstea D,Santo L,Hu Y,Tai YT,Nahar S,Mimura N,Fabre C,Raje N,Munshi N,Richardson P,Anderson KC

    更新日期:2010-10-28 00:00:00

  • Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.

    abstract::Approximately 20% of children with acute lymphoblastic leukemia (ALL) relapse because of failure to eradicate the disease. Current drug efficacy studies focus on reducing leukemia cell burden. However, if drugs have limited effects on leukemia-initiating cells (LICs), then these cells may expand and eventually cause r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-08-448852

    authors: Diamanti P,Cox CV,Moppett JP,Blair A

    更新日期:2013-02-21 00:00:00

  • Mechanism of transcriptional activation of the immediate early gene Egr-1 in response to PIXY321.

    abstract::Studies with the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin-3 (IL-3) fusion protein, PIXY321, demonstrated enhanced biological activity of this molecule in comparison with GM-CSF or IL-3 alone or in combination. Experiments were performed to study the mechanisms resulting in PIXY321-induced ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mignacca RC,Lee HJ,Kwon EM,Sakamoto KM

    更新日期:1996-08-01 00:00:00

  • Serum CD44 in malignant lymphoma: an association with treatment response.

    abstract::CD44, a cell surface glycoprotein, is involved in lymphocyte trafficking from the blood to lymphatic tissues, and is of importance in dissemination of lymphoma. A variant form of CD44 that has additional amino acids in the common protein backbone (CD44v6) also seems to play a role in the metastatic dissemination of ma...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ristamäki R,Joensuu H,Salmi M,Jalkanen S

    更新日期:1994-07-01 00:00:00

  • Identification of a restriction fragment length polymorphism involving the oncogene ETS-1 on chromosome 11q23.

    abstract::Twenty four samples of DNA from 23 unrelated individuals were analyzed for the presence of a novel restriction fragment length polymorphism (RFLP) involving the proto-oncogene ETS-1 at an Xba I site. Four samples from unrelated individuals lacked an Xba I site, giving rise to a longer restriction fragment detectable b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Savage PD,Hanson CA,Kersey JH

    更新日期:1987-07-01 00:00:00

  • Thrombopoietin therapy increases platelet yields in healthy platelet donors.

    abstract::The recombinant thrombopoietins have been shown to be effective stimulators of platelet production in cancer patients. It was therefore of interest to determine if one of these, pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF), could be used to increase platelet counts and conseque...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood.v98.5.1339

    authors: Kuter DJ,Goodnough LT,Romo J,DiPersio J,Peterson R,Tomita D,Sheridan W,McCullough J

    更新日期:2001-09-01 00:00:00

  • Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro.

    abstract::The tyrosine kinase receptor fetal liver kinase 1 (Flk-1) plays a crucial role in vasculogenesis and angiogenesis, but its target genes remain elusive. Comparing Flk-1(+/+) with Flk-1(-/-) embryonic stem (ES) cells, we identified transcripts regulated by the vascular endothelial growth factor A (VEGF-A)/Flk-1 pathway ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3827

    authors: Zippo A,De Robertis A,Bardelli M,Galvagni F,Oliviero S

    更新日期:2004-06-15 00:00:00

  • Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.

    abstract::The extended use of brentuximab-vedotin was reported for CD30(+) nonanaplastic peripheral T-cell lymphomas (PTCLs) with promising efficacy. CD30 status assessment is thus a critical factor for therapeutic decision, but the reliability of immunohistochemistry (IHC) in evaluating its expression remains to be defined. Th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-584953

    authors: Bossard C,Dobay MP,Parrens M,Lamant L,Missiaglia E,Haioun C,Martin A,Fabiani B,Delarue R,Tournilhac O,Delorenzi M,Gaulard P,de Leval L

    更新日期:2014-11-06 00:00:00

  • Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.

    abstract::We prospectively studied 98 chronic myeloid leukemia (CML) patients after bone marrow transplantation by competitive polymerase chain reaction to detect and quantify leukemia-specific BCR-ABL mRNA. Of 69 patients who had persistently undetectable, decreasing, or low BCR-ABL levels ( < 50 transcripts/microgram RNA) on ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lin F,van Rhee F,Goldman JM,Cross NC

    更新日期:1996-05-15 00:00:00

  • Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.

    abstract::Cancer cells require glutamine to adapt to increased biosynthetic activity. The limiting step in intracellular glutamine catabolism involves its conversion to glutamate by glutaminase (GA). Different GA isoforms are encoded by the genes GLS1 and GLS2 in humans. Herein, we show that glutamine levels control mitochondri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-621870

    authors: Jacque N,Ronchetti AM,Larrue C,Meunier G,Birsen R,Willems L,Saland E,Decroocq J,Maciel TT,Lambert M,Poulain L,Hospital MA,Sujobert P,Joseph L,Chapuis N,Lacombe C,Moura IC,Demo S,Sarry JE,Recher C,Mayeux P,Tambur

    更新日期:2015-09-10 00:00:00

  • Gain of von Willebrand factor-binding function by mutagenesis of a species-conserved residue within the leucine-rich repeat region of platelet glycoprotein Ibalpha.

    abstract::Glycoprotein (GP) Ibalpha, a member of the leucine-rich repeat (LRR) protein family, mediates platelet adhesion to immobilized von Willebrand factor (VWF). We investigated the role in VWF binding of charged residues in the LRR region of GP Ibalpha that are conserved in human, canine, and murine proteins. Substitution ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0514

    authors: Peng Y,Shrimpton CN,Dong JF,López JA

    更新日期:2005-09-15 00:00:00

  • Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray.

    abstract::An imbalance between cellular apoptosis and survival may be critical for the pathogenesis of lymphoma. Therefore, the gene expression pattern in lymph node preparations from patients with mantle cell lymphoma (MCL) was compared to the pattern in nonmalignant hyperplastic lymph nodes (HLs). Oligonucleotide microarray a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.787

    authors: Hofmann WK,de Vos S,Tsukasaki K,Wachsman W,Pinkus GS,Said JW,Koeffler HP

    更新日期:2001-08-01 00:00:00

  • Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.

    abstract::A global phase 3 study evaluated the pharmacokinetics, efficacy, and safety of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in 63 previously treated male patients (12-61 years) with severe hemophilia B (factor IX [FIX] activity ≤2%). The study included 2 groups: group 1 patients recei...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2015-09-669234

    authors: Santagostino E,Martinowitz U,Lissitchkov T,Pan-Petesch B,Hanabusa H,Oldenburg J,Boggio L,Negrier C,Pabinger I,von Depka Prondzinski M,Altisent C,Castaman G,Yamamoto K,Álvarez-Roman MT,Voigt C,Blackman N,Jacobs I,PROLONG

    更新日期:2016-04-07 00:00:00

  • IL-1β, in contrast to TNFα, is pivotal in blood-induced cartilage damage and is a potential target for therapy.

    abstract::Joint bleeding after (sports) trauma, after major joint surgery, or as seen in hemophilia in general leads to arthropathy. Joint degeneration is considered to result from the direct effects of blood components on cartilage and indirectly from synovial inflammation. Blood-provided proinflammatory cytokines trigger chon...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-03-635524

    authors: van Vulpen LF,Schutgens RE,Coeleveld K,Alsema EC,Roosendaal G,Mastbergen SC,Lafeber FP

    更新日期:2015-11-05 00:00:00

  • Ferritin iron absorption in man.

    abstract::The iron absorption from ferritin and hemosiderin biosynthetically labeled with radioiron was studied in 108 subjects. The geometric mean absorption of ferritin iron in both normal and iron-deficient subjects was 1.9 percent. Its mean absorption ranged from 0.9 percent in normal subjects to 2.5 percent in subjects wit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Layrisse M,Martínez-Torres C,Renzy M,Leets I

    更新日期:1975-05-01 00:00:00

  • HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling.

    abstract::Human immunodeficiency virus type 1 (HIV-1) uses the chemokine receptors CCR5 and CXCR4 as coreceptors for entry. It was recently demonstrated that HIV-1 glycoprotein 120 (gp120) elevated calcium and activated several ionic signaling responses in primary human macrophages, which are important targets for HIV-1 in vivo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.10.2909

    authors: Del Corno M,Liu QH,Schols D,de Clercq E,Gessani S,Freedman BD,Collman RG

    更新日期:2001-11-15 00:00:00

  • Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload.

    abstract::We compared 48-hour urinary iron excretion after a twice-daily subcutaneous bolus injection of deferoxamine and after 12 hours of subcutaneous continuous infusion of the drug in 27 patients with iron overload (mean age, 55.7 years). In most patients, the iron overload was due to multiple transfusions administered duri...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Franchini M,Gandini G,de Gironcoli M,Vassanelli A,Borgna-Pignatti C,Aprili G

    更新日期:2000-05-01 00:00:00

  • N-Glycans of ADAMTS13 modulate its secretion and von Willebrand factor cleaving activity.

    abstract::Severe deficiency of ADAMTS13, a plasma metalloprotease, leads to thrombotic thrombocytopenic purpura. ADAMTS13 contains 10 putative N-glycosylation sites in or near its metalloprotease sequence, spacer region, thrombospondin type 1 repeat no. 4 (TSR no. 4), and CUB domains. Tunicamycin treatment markedly decreased th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-167775

    authors: Zhou W,Tsai HM

    更新日期:2009-01-22 00:00:00

  • Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells.

    abstract::The pathologic hallmarks of thrombotic thrombocytopenic purpura (TTP) include endothelial cell proliferation and subendothelial hyalin deposits in the microvasculature leading to symptomatic thrombotic occlusions. Plasma or sera from three consecutive patients with TTP were subjected to multiple analyses to determine ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Burns ER,Zucker-Franklin D

    更新日期:1982-10-01 00:00:00